Intractable Epilepsy Clinical Trial
Official title:
Evaluating the Tolerance, Compliance, Acceptability and Safety of Ketocal 2.5:1 LQ, a Nutritionally Complete Liquid Feed for Use as Part of the Ketogenic Diet (KD) in Children 8+ Years, Adolescents and Adults With Intractable Epilepsy or Other Disorders Where the KD is Indicated
An evaluation of the tolerance, compliance, acceptability and safety of a nutritionally complete liquid feed for use as part of the ketogenic diet (KD) in children 8+ years, adolescents and adults with intractable epilepsy or other disorders where the KD is indicated.
An evaluation of the tolerance, compliance, acceptability and safety of a nutritionally
complete liquid feed for use as part of the ketogenic diet (KD) in children 8+ years,
adolescents and adults with intractable epilepsy or other disorders where the KD is
indicated.
Study is conducted over 59 days:
3 day baseline period - Patient continues on whatever dietary regimen they were on before
joining the study (this may be a ketogenic diet for existing patients).
28 day control period - Patient begins ketogenic diet (if they are not already on one), and
continues this for 28 days WITHOUT the study product. Patients already on a ketogenic diet
continue this as normal.
28 day intervention period - A set amount of the study product is incorporated into the
patient's ketogenic diet.
Data is captured by the HCP in the case report form at baseline, mid study and end of
intervention, and by the patient daily throughout in a patient questionnaire.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04810832 -
EXPRESON-IN : Intracerebral Recordings of P3a Responses to Expressive Own-names
|
N/A | |
Not yet recruiting |
NCT00647322 -
The Impact of Reducing Overtreatment on Quality of Life in Children With Refractory Epilepsy
|
Phase 4 | |
Recruiting |
NCT02846272 -
Diffusion Tensor and Functional Connectivity Imaging in Pediatric Epilepsy: Imaging/Histology Correlation
|
N/A | |
Terminated |
NCT03955432 -
Long-term Cardiac Monitoring in Epilepsy
|
N/A | |
Completed |
NCT03860298 -
Safety of Using NaviFUS System in Patients With Drug Resistant Epilepsy
|
N/A | |
Active, not recruiting |
NCT03916848 -
Novel Network Analysis of Intracranial Stereoelectroencephalography
|
N/A | |
Recruiting |
NCT04219995 -
Pilot Trial to Evaluate The Effect of Oral Methylprednisolone on Seizure Frequency in Children With Epilepsy
|
Phase 1/Phase 2 | |
Terminated |
NCT04650204 -
Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy
|
Phase 4 | |
Recruiting |
NCT05600738 -
Network Effects of Therapeutic Deep Brain Stimulation
|
N/A | |
Withdrawn |
NCT02934854 -
Biomarker for Creatine Deficiency Syndromes (BioCDS)
|
||
Completed |
NCT02915211 -
Evaluation of Keyo in Children With Epilepsy
|
N/A |